Regional differences in striatal dopamine uptake and release associated with recovery from MPTP-induced parkinsonism: An in vivo electrochemical study

Journal of Neurochemistry

Volumn 72, Issue 2, 1999, Pages 724-733

  Rothblat, David S ^a   Schneider, J S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Caudate; Dopamine transporter; MPTP; Parkinsonism; Uptake

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; DOPAMINE TRANSPORTER; POTASSIUM CHLORIDE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAT; CAUDATE NUCLEUS; CONTROLLED STUDY; CONVALESCENCE; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; ELECTROCHEMICAL ANALYSIS; FEMALE; IN VIVO STUDY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OXIDATION REDUCTION REACTION; PARKINSONISM; PRIORITY JOURNAL;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BEHAVIOR, ANIMAL; CARRIER PROTEINS; CATS; CAUDATE NUCLEUS; DOPAMINE; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ELECTROCHEMISTRY; FEMALE; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; OXIDATION-REDUCTION; PARKINSON DISEASE, SECONDARY; POTASSIUM CHLORIDE;

EID: 0032937181     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0720724.x     Document Type: Article

References (32)

1. Altar C. and Marion M. (1989) Preservation of dopamine release in the denervated striatum. Neurosci. Lett. 96, 329-334.
2. Annunziato L., Leblanc P., Kordan C., and Weiner R. (1980) Differences in the kinetics of dopamine uptake in the synaptosome preparations of the median eminence relative to other dopaminergically innervated brain regions. Neuroendocrinology 31, 316-320.
3. Bannon M. J. and Whitty C. J. (1997) Age-related and regional differences in dopamine transporter mRNA expression in human midbrain. Neurology 48, 969-977.
4. Bannon M. J., Poosch M. S., Goebel D. J., Cassin B., and Kapatos G. (1992) Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. Proc. Natl. Acad. Sci. USA 89, 7095-7099.
5. Berman A. J. and Jones E. G. (1982) The Thalamus and Basal Telencephalon of the Cat. A Cytoarchitectonic Atlas with Sterotaxic Coordinates. University of Wisconsin Press, Madison, Wisconsin.
6. Cass W. A., Gerhardt G. A., Zhang Z., Ovadia A., and Gash D. M. (1995) Increased dopamine clearance in the non-lesioned striatum of rhesus monkeys with unilateral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) striatal lesions. Neurosci. Lett. 185, 52-55.
7. Castaneda E., Whishaw I. Q., and Robinson T. E. (1990) Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J. Neurosci. 10, 1847-1854.
8. Demarest K. and Moore K. (1998) Lack of high affinity transport system for dopamine in the median eminence and posterior pituitary. Brain Res. 171, 545-551.
9. Doucet G., Descarries L., and Garcia S. (1986) Quantification of the dopamine innervation in adult rat neostriatum. Neuroscience 19, 427-445.
10. Frohna P. A., Rothblat D. S., Joyce J. N., and Schneider J. S. (1995) Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism. Synapse 19, 46-55.
11. Garris P. A. and Wightman R. M. (1994) Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: in vivo voltammetric study. J. Neurosci. 14, 442-450.
12. Garris P. A., Walker Q. D., and Wightman R. M. (1997) Dopamine release and uptake rates both decrease in partially denervated striatum in proportion to the loss of dopamine terminals. Brain Res. 753, 225-234.
13. Gerhardt G. A. and Palmer M. R. (1987) Characterization of the techniques of pressure ejection and microiontophoresis using in vivo electrochemistry. J. Neurosci. Methods 22, 147-159.
14. Gerhardt G., Rose G., Stomberg I., Conboy G., Olson L., Jonsson G., and Hoffer B. (1985) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse: an in vivo electrochemical study. J. Pharmacol. Exp. Ther. 235, 259-265.
15. Hefti F., Enz A., and Melamed E. (1985) Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurons by drugs. Neuropharmacology 24, 19-23.
16. 3H]mazindol binding sites in rat striatum by dopaminergic agents. Eur. J. Pharmacol. 250, 261-266.
17. Joyce J. N., Smutzer G., Whitty C. J., Myers A., and Bannon M. J. (1997) Differential modification of dopamine transporter and tyrosine hydroxylase mRNA's in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease. Mov. Disord. 12, 885-897.
18. Luthman J., Friedman M., Hoffer B. J., and Gerhardt G. A. (1993) In vivo electrochemical measurements of exogenous dopamine clearance in normal and neonatal 6-hydroxydopamine-treated rat striatum. Exp. Neurol. 122, 273-282.
19. Miller G. W., Staley J. K., Heilman C. J., Perez J. T., Mash D. C., Rye D. B., and Levey A. L. (1997) Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Ann. Neurol. 41, 530-539.
20. Pentney R.-J. W. and Gratton A. (1991) Effects of local delta and mu opioid receptor activation on basal and stimulated dopamine release in striatum and nucleus accumbens of rat: an in vivo electrochemical study. Neuroscience 45, 95-102.
21. Rothblat D. S. and Schneider J. S. (1993) Responses of caudate neurons to stimulation of intrinsic and peripheral afferents in normal, symptomatic and recovered MPTP-treated cats. J. Neurosci. 13, 4372-4378.
22. Rothblat D. S. and Schneider J. S. (1994) Spontaneous functional recovery from parkinsonism is not due to reinnervation of the dorsal striatum by residual dopaminergic neurons. Brain Res. Bull. 34, 309-312.
23. Schneider J. S. and Markham C. H. (1986) Neurotoxic effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the cat. Tyrosine hydroxylase immunohistochemistry. Brain Res. 373, 258-267.
24. Schneider J. S. and Rothblat D. S. (1991) Neurochemical evaluation of the striatum in symptomatic and recovered MPTP-treated cats. Neuroscience 44, 421-429.
25. Schneider J. S., Yuwiler A., and Markham C. H. (1986) Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior, histology and biochemistry. Exp. Neurol. 91, 293-307.
26. Schneider J. S., Rothblat D. S., and DiStefano L. (1993) Functional recovery from experimental parkinsonsim in cats is accompanied by partial recovery of extracellular but not tissue levels of dopamine in the dorsal lateral caudate nucleus. Neurodegeneration 2, 209-212.
27. Schneider J. S., Rothblat D. S., and DiStefano L. (1994) Volume transmission of dopamine over large distances may contribute to recovery from experimental parkinsonism. Brain Res. 643, 86-91.
28. Uhl G. R., Walther D., Mash D., Faucheux B., and Javoy A. F. (1994) Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons. Ann. Neurol. 35, 494-498.
29. Volkow N. D., Fowler J. S., Wang G. J., Logan J., and Schlayer D. (1994) Decreased dopamine transporters with age in healthy human subjects. Ann. Neurol. 36, 237-239.
30. Zahniser N. R., Larson G. A., and Gerhardt G. A. (1996) Dopamine clearance rate in the rat striatum: effects of uptake inhibitors and dopamine concentration. Soc. Neurosci. Abstr. 22, 1577.
31. Zigmond M. J., Acheson A. L., Stachowiak M. K., and Stricker E. M. (1984) Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. Arch. Neurol. 41, 856-861.
32. Zigmond M. J., Abercrombie E. D., Berger T. W., Grace A. A., and Stricker E. M. (1990) Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci. 13, 290-296.